Global Longitudinal Strain Is Associated with Mortality in Patients with Multiple Myeloma
- PMID: 37048679
- PMCID: PMC10095531
- DOI: 10.3390/jcm12072595
Global Longitudinal Strain Is Associated with Mortality in Patients with Multiple Myeloma
Abstract
Patients with multiple myeloma (MM) are at a high risk for developing cardiovascular complications. Global longitudinal strain (GLS) can detect early functional impairment before structural abnormalities develop. It remains unknown if reduced GLS is associated with reduced survival in patients with MM. We conducted a retrospective cohort analysis of patients diagnosed with MM between 1 January 2000 and 31 December 2017 at our institution. Patients with a 2D transthoracic echocardiogram completed within 1 year of MM diagnosis, left ventricular ejection fraction (LVEF) greater than 40%, and no history of myocardial infarction prior to MM diagnosis were included. GLS was measured using an artificial-intelligence-powered software (EchoGo Core), with reduced GLS defined as an absolute value of <18%. The primary outcome of interest was overall survival since myeloma diagnosis. Our cohort included 242 patients with a median follow up of 4.28 years. Fifty-two (21.5%) patients had reduced average GLS. Patients with reduced GLS were more likely to have an IVSd ≥ 1.2cm, E/E' > 9.6, LVEF/GLS > 4.1, higher LV mass index, and low-voltage ECG. A Total of 126 (52.1%) deaths occurred during follow-up. Overall survival was lower among patients with reduced GLS (adjusted HR: 1.81, CI: 1.07-3.05).
Keywords: ECG; Echo; global longitudinal strain; multiple myeloma; survival.
Conflict of interest statement
A.V. has received research funding from GlaxoSmithKline, BMS, Jannsen, Incyte, MedPacto, Celgene, Novartis, Curis, Prelude and Eli Lilly and Company, has received compensation as a scientific advisor to Novartis, Stelexis Therapeutics, Acceleron Pharma, Bakx Therapeutics and Celgene, and has equity ownership in Throws Exception and Stelexis Therapeutics. L.S. has received consulting honorarium from Amgen and Regeneron. P.A.P. has received research support from Ultromics. L.Z. has received honorarium from Bristol Myers Squibb. The remaining authors have nothing to disclose.
Figures


Similar articles
-
Artificial intelligence calculated global longitudinal strain and left ventricular ejection fraction predicts cardiac events and all-cause mortality in patients with chest pain.Echocardiography. 2023 Dec;40(12):1356-1364. doi: 10.1111/echo.15714. Epub 2023 Nov 15. Echocardiography. 2023. PMID: 37964624
-
Incremental prognostic value of speckle tracking echocardiography and early follow-up echo assessment in predicting left ventricular recovery after reperfusion for ST-segment elevation myocardial infarction (STEMI).Echocardiography. 2024 Jan;41(1):e15725. doi: 10.1111/echo.15725. Epub 2023 Dec 11. Echocardiography. 2024. PMID: 38078679
-
Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis.Echocardiography. 2023 Mar;40(3):188-195. doi: 10.1111/echo.15516. Epub 2023 Jan 9. Echocardiography. 2023. PMID: 36621915
-
Prognostic Value of Preprocedural LV Global Longitudinal Strain for Post-TAVR-Related Morbidity and Mortality: A Meta-Analysis.JACC Cardiovasc Imaging. 2023 Mar;16(3):332-341. doi: 10.1016/j.jcmg.2023.01.005. JACC Cardiovasc Imaging. 2023. PMID: 36889849
-
Prognostic Value of Global Longitudinal Strain in Asymptomatic Aortic Stenosis: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2022 Feb 18;9:778027. doi: 10.3389/fcvm.2022.778027. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35252381 Free PMC article.
References
-
- Madan S., Dispenzieri A., Lacy M.Q., Buadi F., Hayman S.R., Zeldenrust S.R., Rajkumar S.V., Gertz M.A., Kumar S.K. Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma. Mayo. Clin. Proc. 2010;85:232–238. doi: 10.4065/mcp.2009.0547. - DOI - PMC - PubMed
-
- Stokke T.M., Hasselberg N.E., Smedsrud M.K., Sarvari S.I., Haugaa K.H., Smiseth O.A., Edvardsen T., Remme E.W. Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain. J. Am. Coll. Cardiol. 2017;70:942–954. doi: 10.1016/j.jacc.2017.06.046. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous